Literature DB >> 18525201

Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome.

Jennifer A Frontera1, Augusto Parra, Daichi Shimbo, Andres Fernandez, J Michael Schmidt, Patricia Peter, Jan Claassen, Katja E Wartenberg, Fred Rincon, Neeraj Badjatia, Andrew Naidech, E Sander Connolly, Stephan A Mayer.   

Abstract

OBJECTIVE: Serious cardiac arrhythmias have been described in approximately 5% of patients after subarachnoid hemorrhage (SAH). The aim of this study was to identify the frequency, risk factors and clinical impact of cardiac arrhythmia after SAH.
METHODS: We prospectively studied 580 spontaneous SAH patients and identified risk factors and complications associated with the development of clinically significant arrhythmia. Multiple logistic regression analysis was used to calculate adjusted odds ratios for the effect of arrhythmia on hospital complications and 3-month outcome, as measured by the modified Rankin Scale, after controlling for age, neurological grade, APACHE-2 physiologic subscore, brain herniation and aneurysm size.
RESULTS: Arrhythmia occurred in 4.3% (n = 25) of patients. Atrial fibrillation and flutter were the most common arrhythmias, occurring in 76% (n = 19) of these patients. Admission predictors of cardiac arrhythmia included older age, history of arrhythmia and abnormal admission electrocardiogram (all p < 0.05). After adjusting for length of stay, hospital complications associated with arrhythmia included myocardial ischemia, hyperglycemia, and herniation (all p < 0.05). Arrhythmia was associated with an excess ICU stay of 5 days (p = 0.002). After adjusting for other predictors of outcome, arrhythmia was associated with an increased risk of death (adjusted OR 8.0, 95% confidence interval 1.9-34.0, p = 0.005), and death or severe disability (adjusted OR 6.9, 95% confidence interval 1.5-32.0, p = 0.014).
CONCLUSIONS: Clinically important arrhythmias, most often atrial fibrillation or flutter, occurred in 4% of SAH patients. Arrhythmias are associated with an increased risk of cardiovascular comorbidity, prolonged hospital stay and poor outcome or death after SAH, after adjusting for other predictors of poor outcome. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18525201      PMCID: PMC2909703          DOI: 10.1159/000135711

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  25 in total

Review 1.  Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.

Authors:  S E Capes; D Hunt; K Malmberg; P Pathak; H C Gerstein
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

2.  ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage.

Authors:  W J Schuiling; A Algra; A W de Weerd; P Leemans; G J E Rinkel
Journal:  Acta Neurochir (Wien)       Date:  2006-06-23       Impact factor: 2.216

3.  Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities.

Authors:  J G Zaroff; G A Rordorf; J B Newell; C S Ogilvy; J R Levinson
Journal:  Neurosurgery       Date:  1999-01       Impact factor: 4.654

4.  Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU.

Authors:  P Reinelt; G D Karth; A Geppert; G Heinz
Journal:  Intensive Care Med       Date:  2001-09       Impact factor: 17.440

5.  Supraventricular arrhythmias in intensive care unit patients: short and long-term consequences.

Authors:  Sergei Goodman; Taras Shirov; Charles Weissman
Journal:  Anesth Analg       Date:  2007-04       Impact factor: 5.108

6.  Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Kurt T Kreiter; Nazli Janjua; Noeleen Ostapkovich; Augusto Parra; Christopher Commichau; E Sander Connolly; Stephan A Mayer; Brian-Fred M Fitzsimmons
Journal:  Stroke       Date:  2005-01-20       Impact factor: 7.914

7.  Hyperglycemia after SAH: predictors, associated complications, and impact on outcome.

Authors:  Jennifer A Frontera; Andres Fernandez; Jan Claassen; Michael Schmidt; H Christian Schumacher; Katja Wartenberg; Richard Temes; Augusto Parra; Noeleen D Ostapkovich; Stephan A Mayer
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

8.  Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited.

Authors:  J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

9.  Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Kurt T Kreiter; Nazli Janjua; Noeleen D Ostapkovich; Augusto Parra; Christopher Commichau; Brian-Fred M Fitzsimmons; E Sander Connolly; Stephan A Mayer
Journal:  Circulation       Date:  2005-11-01       Impact factor: 29.690

10.  Impact of medical complications on outcome after subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

View more
  25 in total

1.  Predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a cardiac focus.

Authors:  Khalil Yousef; Elizabeth Crago; Chien-Wen Kuo; Michael Horowitz; Marilyn Hravnak
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 2.  Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage.

Authors:  Nicolas Bruder; Alejandro Rabinstein
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 3.  Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: is there a proven role?

Authors:  Toshimasa Okabe; Mitul Kanzaria; Fred Rincon; Walter K Kraft
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 4.  Neurogenic Stunned Myocardium in Severe Neurological Injury.

Authors:  Benjamin B Kenigsberg; Christopher F Barnett; Jeffrey C Mai; Jason J Chang
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

Review 5.  Autonomic dysfunction syndromes after acute brain injury.

Authors:  Courtney Takahashi; Holly E Hinson; Ian J Baguley
Journal:  Handb Clin Neurol       Date:  2015

6.  Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Michael Crimmins; Hector Lantigua; Andres Fernandez; Chris Zammit; Cristina Falo; Sachin Agarwal; Jan Claassen; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

7.  Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage.

Authors:  Marilyn Hravnak; J Michael Frangiskakis; Elizabeth A Crago; Yuefang Chang; Masaki Tanabe; John Gorcsan; Michael B Horowitz
Journal:  Stroke       Date:  2009-08-27       Impact factor: 7.914

Review 8.  Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880.

Authors:  Stefan Katharios-Lanwermeyer; Jon-Erik Holty; Marissa Person; James Sejvar; Dana Haberling; Heather Tubbs; Dana Meaney-Delman; Satish K Pillai; Nathaniel Hupert; William A Bower; Katherine Hendricks
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

9.  Complete heart block as the presenting feature in subarachnoid haemorrhage.

Authors:  Joshua Pepper; Ciara Fenton; Howard Brydon
Journal:  BMJ Case Rep       Date:  2017-11-30

10.  Acute cardiac injury after subarachnoid haemorrhage: two case reports.

Authors:  Marcello Marcì; Paolino Savatteri; Antonino Pizzuto; Giuseppe Giammona; Baldassare Renda; Francesca Lojacono; Nicola Sanfilippo
Journal:  Cases J       Date:  2009-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.